Omalizumab and Mepolizumab in the Landscape of Biological Therapy for Severe Asthma in Children: How to Choose?

Italian Journal of Pediatrics - United Kingdom
doi 10.1186/s13052-019-0737-4
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC